Mouse models for the genetic study of tuberculosis susceptibility

Briefings in Functional Genomics and Proteomics

Volumn 4, Issue 3, 2005, Pages 277-292

  Di Pietrantonio, Tania ^a   Schurr, Erwin ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Forward genetics; Mice; Mycobacterium tuberculosis; Quantitative trait loci (QTL); Reverse genetics; Susceptibility

Indexed keywords

BCG VACCINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 23; INTERLEUKIN 6; TUBERCULOSTATIC AGENT;

ANIMAL MODEL; CACHEXIA; CELLULAR IMMUNITY; CHROMOSOME 1; DISEASE SEVERITY; GENETIC ANALYSIS; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GRANULOMA; HUMAN; INFECTION CONTROL; MOLECULAR CLONING; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; QUANTITATIVE TRAIT LOCUS; REVIEW; SURVIVAL; T LYMPHOCYTE; TUBERCULOSIS;

ANIMALS; BCG VACCINE; CLONING, MOLECULAR; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; GENETIC PREDISPOSITION TO DISEASE; INTERFERON TYPE II; LUNG; MICE; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; POLYMORPHISM, GENETIC; QUANTITATIVE TRAIT LOCI; TUBERCULOSIS; TUBERCULOSIS VACCINES;

ANIMALIA; BACTERIA (MICROORGANISMS); MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS;

EID: 30344444285     PISSN: 14739550     EISSN: 14774062     Source Type: Journal    
DOI: 10.1093/bfgp/4.3.277     Document Type: Review

References (124)

1. Dye, C., Scheele, S., Dolin, P. et al. (1999), 'Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project', JAMA, Vol. 282, pp. 677-686.
2. Murray, C. J., Styblo, K. and Rouillon, A. (1990), 'Tuberculosis in developing countries: burden, intervention and cost', Bull. Int. Union Tuberc. Lung Dis., Vol. 65, pp. 6-24.
3. Lurie, M. B. (1941), 'Hereditary, constitution and tuberculosis. An experimental study', Am. Rev. Tuberc., Vol. 44, pp. 1-125.
4. Pierce, C., Dubos, R. and Middlebrook, G. (1947), 'Infection of mice with mammalian tubercle bacilli grown in Tween-albumin liquid medium', J. Exp. Med., Vol. 86, pp. 159-174.
5. Gray, D. F. and Martinson, M. W. (1952), 'Detection of small numbers of tubercle bacilli from dispersed cultures, using mice, guinea pigs, and artificial media', Am. Rev. Tuberc., Vol. 65, pp. 572-588.
6. Gray, D. F., Graham-Smith, H. and Noble, J. L. (1960), 'Variations in natural resistance to tuberculosis', J. Hyg. (Lond), Vol. 58, pp. 215-227.
7. Lynch, C. J., Pierce-Chase, C. H. and Dubos, R. (1965), 'A genetic study of susceptibility to experimental tuberculosis in mice infected with mammalian tubercle bacilli', J. Exp. Med., Vol. 121, pp. 1051-1070.
8. Bellamy, R., Ruwende, C., Corrah, T. et al. (1998), 'Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans', N. Engl. J. Med., Vol. 338, pp. 640-644.
9. Abel, L., Sanchez, F. O., Oberti, J. et al. (1998), 'Susceptibility to leprosy is linked to the human NRAMP1 gene', J. Infect. Dis., Vol. 177, pp. 133-145.
10. Marquet, S., Sanchez, F. O., Arias, M. et al. (1999), 'Variants of the human NRAMP1 gene and altered human immunodeficiency virus infection susceptibility', J. Infect. Dis., Vol. 180, pp. 1521-1525.
11. Gros, P., Skamene, E. and Forget, A. (1981), 'Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice', J. Immunol., Vol. 127, pp. 2417-2421.
12. Skamene, E., Gros, P., Forget, A. et al. (1982), 'Genetic regulation of resistance to intracellular pathogens', Nature, Vol. 297, pp. 506-509.
13. Bradley, D. J., Taylor, B. A., Blackwell, J. et al. (1979), 'Regulation of Leishmania populations within the host. III. Mapping of the locus controlling susceptibility to visceral leishmaniasis in the mouse', Clin. Exp. Immunol., Vol. 37, pp. 7-14.
14. Plant, J. and Glynn, A. A. (1979), 'Locating salmonella resistance gene on mouse chromosome 1', Clin. Exp. Immunol., Vol. 37, pp. 1-6.
15. Malo, D., Vidal, S. M., Hu, J. et al. (1993), 'High-resolution linkage map in the vicinity of the host resistance locus Bcg', Genomics, Vol. 16, pp. 655-663.
16. Malo, D., Vidal, S., Lieman, J. H. et al. (1993), 'Physical delineation of the minimal chromosomal segment encompassing the murine host resistance locus Bcg', Genomics, Vol. 17, pp. 667-675.
17. Vidal, S. M., Malo, D., Vogan, K. et al. (1993), 'Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg', Cell, Vol. 73, pp. 469-485.
18. Malo, D., Vogan, K., Vidal, S. et al. (1994), 'Haplotype mapping and sequence analysis of the mouse Nramp gene predict susceptibility to infection with intracellular parasites', Genomics, Vol. 23, pp. 51-61.
19. Gruenheid, S., Canonne-Hergaux, F., Gauthier, S. et al. (1999), 'The iron transport protein NRAMP2 is an integral membrane glycoprotein that colocalizes with transferrin in recycling endosomes', J. Exp. Med., Vol. 189, pp. 831-841.
20. Hackam, D. J., Rotstein, O. D., Zhang, W. et al. (1998), 'Host resistance to intracellular infection: Mutation of natural resistance-associated macrophage protein 1 (Nramp1) impairs phagosomal acidification', J. Exp. Med., Vol. 188, pp. 351-364.
21. Lam-Yuk-Tseung, S. and Gros, P. (2003), 'Genetic control of susceptibility to bacterial infections in mouse models', Cell Microbiol., Vol. 5, pp. 299-313.
22. Medina, E. and North, R. J. (1996). 'Evidence inconsistent with a role for the Bcg gene (Nramp1) in resistance of mice to infection with virulent Mycobacterium tuberculosis', J. Exp. Med., Vol. 183, pp. 1045-1051.
23. North, R. J., LaCourse, R., Ryan, L. and Gros, P. (1999), 'Consequence of Nramp1 deletion to Mycobacterium tuberculosis infection in mice', Infect. Immun., Vol. 67, pp. 5811-5814.
24. Cellier, M., Govoni, G., Vidal, S. et al. (1994), 'Human natural resistance-associated macrophage protein: cDNA cloning, chromosomal mapping, genomic organization, and tissue-specific expression', J. Exp. Med., Vol. 180, pp. 1741-1752.
25. Gao, P. S., Fujishima, S., Mao, X. Q. et al. (2000), 'Genetic variants of NRAMP1 and active tuberculosis in Japanese populations. International Tuberculosis Genetics Team', Clin. Genet., Vol. 58, pp. 74-76.
26. Cervino, A. C., Lakiss, S., Sow, O. and Hill, A. V. (2000), 'Allelic association between the NRAMP1 gene and susceptibility to tuberculosis in Guinea-Conakry', Ann. Hum. Genet., Vol. 64, pp. 507-512.
27. Ryu, S., Park, Y. K., Bai, G. H. et al. (2000), '3′UTR polymorphisms in the NRAMP1 gene are associated with susceptibility to tuberculosis in Koreans', Int. J. Tuberc. Lung Dis., Vol. 4, pp. 577-580.
28. Delgado, J. C., Baena, A., Thim, S. and Goldfeld, A. E. (2002), 'Ethnic-specific genetic associations with pulmonary tuberculosis', J. Infect. Dis., Vol. 186, pp. 1463-1468.
29. Fitness, J., Floyd, S., Warndorff. D. K. et al. (2004), 'Large-scale candidate gene study of tuberculosis susceptibility in the Karonga district of northern Malawi', Am. J. Trop. Med. Hyg., Vol. 71, pp. 341-349.
30. Liu, W., Cao, W. C., Zhang, C. Y. et al. (2004), 'VDR and NRAMP1 gene polymorphisms in susceptibility to pulmonary tuberculosis among the Chinese Han population: a case-control study', Int. J. Tuberc. Lung Dis., Vol. 8, pp. 428-434.
31. Greenwood, C. M., Fujiwara, T. M., Boothroyd, L.J. et al. (2000), 'Linkage of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large aboriginal Canadian family', Am. J. Hum. Genet., Vol. 67, pp. 405-416.
32. Darvasi, A., Weinreb, A., Minke, V. et al. (1993), 'Detecting marker-QTL linkage and estimating QTL gene effect and map location using a saturated genetic map', Genetics, Vol. 134, pp, 943-951.
33. Jansen, R. C. (1993), 'Interval mapping of multiple quantitative trait loci', Genetics, Vol. 135, pp. 205-211.
34. Lavebratt, C., Apt, A. S., Nikonenko, B. V. et al. (1999), 'Severity of tuberculosis in mice is linked to distal chromosome 3 and proximal chromosome 9', J. Infect. Dis., Vol. 180, pp. 150-155.
35. Sanchez, F., Radaeva, T. V., Nikonenko, B. V. et al. (2003), 'Multigenic control of disease severity after virulent Mycobacterium tuberculosis infection in mice', Infect. Immun., Vol. 71, pp. 126-131.
36. Mitsos, L. M., Carden, L. R., Fortin, A. et al. (2000), 'Genetic control of susceptibility to infection with Mycobacterium tuberculosis in mice', Genes Immun., Vol. 1, pp. 467-477.
37. Mitsos, L. M., Carden, L. R., Ryan, L. et al. (2003), 'Susceptibility to tuberculosis: A locus on mouse chromosome 19 (Trl-4) regulates Mycobacterium tuberculosis replication in the lungs', Proc. Natl. Acad. Sci. USA, Vol. 100, pp. 6610-6615.
38. Kramnik, I., Demant, P. and Bloom, B. B. (1998), 'Susceptibility to tuberculosis as a complex genetic trait: Analysis using recombinant congenic strains of mice', Novartis Found. Symp., Vol. 217, pp. 120-131; discussion 132-137.
39. Kramnik, I., Dietrich, W. F., Demant, P. and Bloom, B. R. (2000), 'Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis', Proc. Natl. Acad. Sci. USA, Vol. 97, pp. 8560-8565.
40. Pan, H., Yan, B. S., Rojas, M. et al. (2005), 'Ipr1 gene mediates innate immunity to tuberculosis', Nature, Vol. 434, pp. 767-772.
41. Kadereit, S., Gewert, D. R., Galabru, J. et al. (1993), 'Molecular cloning of two new interferon-induced, highly related nuclear phosphoproteins', J. Biol. Chem., Vol. 268, pp. 24432-24441.
42. Watashi, K., Hijikata, M., Tagawa, A. et al. (2003), 'Modulation of retinoid signaling by a cytoplasmic viral protein via sequestration of Sp110b, a potent transcriptional corepressor of retinoic acid receptor, from the nucleus', Mol. Cell. Biol., Vol. 23, pp. 7498-7509.
43. Nicewonger, J., Suck, G., Bloch, D. and Swaminathan, S. (2004), 'Epstein-Barr virus (EBV) SM protein induces and recruits cellular Sp110b to stabilize mRNAs and enhance EBV lyric gene expression', J. Virol., Vol. 78, pp. 9412-9422.
44. Reiling, N., Holscher, C., Fehrenbach, A. et al. (2002), 'Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis', J. Immunol., Vol. 169, pp. 3480-3484.
45. Sugawara, I., Yamada, H., Li, C. et al. (2003), 'Mycobacterial infection in TLR2 and TLR6 knockout mice', Microbiol. Immunol., Vol. 47, pp. 327-336.
46. Drennan, M. B., Nicolle, D., Quesniaux, V. J. et al. (2004), 'Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection', Am. J. Pathol., Vol. 164, pp. 49-57.
47. Scanga, C. A., Bafica, A., Feng, C. G. et al. (2004), 'MyD88-deficient mice display a profound loss in resistance to Mycobacterium tuberculosis associated with partially impaired Th1 cytokine and nitric oxide synthase 2 expression', Infect. Immun., Vol. 72, pp. 2400-2404.
48. Fremond, C. M., Yeremeev, V., Nicolle, D. M. et al. (2004), 'Fatal mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88', J. Clin. Invest., Vol. 114, pp. 1790-1799.
49. Sugawara, I., Yamada, H., Mizuno, S. et al. (2003), 'Mycobacterial infection in MyD88-deficient mice', Microbiol. Immunol., Vol. 47, pp. 841-847.
50. Johnson, C. M., Cooper, A. M., Frank, A. A. et al. (1997), 'Mycobacterium tuberculosis aerogenic rechallenge infections in B cell-deficient mice', Tuber. Lung Dis., Vol. 78, pp. 257-261.
51. Vordermeier, H. M., Venkataprasad, N., Harris, D. P. and Ivanyi. J. (1996), 'Increase of tuberculous infection in the organs of B cell-deficient mice', Clin. Exp. Immunol., Vol, 106, pp. 312-316.
52. Bosio, C. M., Gardner, D. and Elkins, K. L. (2000), 'Infection of B cell-deficient mice with CDC 1551, a clinical isolate of Mycobacterium tuberculosis: Delay in dissemination and development of lung pathology', J. Immunol., Vol. 164, pp. 6417-6425.
53. D'Souza, C. D., Cooper, A. M., Frank, A. A. et al. (1997), 'An anti-inflammatory role or gamma delta T lymphocytes in acquired immunity to Mycobacterium tuberculosis', J. Immunol., Vol. 158, pp. 1217-1221.
54. Ladel, C. H., Blum, C., Dreher, A. et al. (1995), 'Protective role of gamina/delta T cells and alpha/beta T cells in tuberculosis', Eur. J. Immunol., Vol. 25, pp. 2877-2881.
55. Mogues, T., Goodrich, M. E., Ryan, L. et al. (2001), 'The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in rnice', J. Exp. Med., Vol. 193, pp. 271-280.
56. Saunders, B. M., Frank, A. A., Orme, I. M. and Cooper. A. M. (2002), 'CD4 is required for the development of a protective granulomatous response to pulmonary tuberculosis', Cell. Immunol., Vol. 216, pp. 65-72.
57. Caruso, A. M., Serbina, N., Klein, E. et al. (1999), 'Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis', J. Immunol., Vol. 162, pp. 5407-5416.
58. D'Souza, C. D., Cooper, A. M., Frank, A. A. et al. (2000), 'A novel nonclassic beta2-microglobulin-restricted mechanism influencing early lymphocyte accumulation and subsequent resistance to tuberculosis in the lung', Am. J. Respir. Cell Mol. Biol., Vol. 23, pp. 188-193.
59. Tascon, R. E., Stavropoulos, E., Lukacs, K. V. and Colston, M. J. (1998), 'Protection against Mycobacterium tuberculosis infection by CD8+ T cells requires the production of gamma interferon', Infect. Immun., Vol. 66, pp. 830-834.
60. Flynn, J. L., Goldstein, M. M., Triebold, K.J. and Bloom, B. R. (1993), 'Major histocompatibility complex class I-restricted T cells are necessary for protection against M. tuberculosis in mice', Infect. Agents Dis., Vol. 2, pp. 259-262.
61. Rolph, M. S., Raupach, B., Kobernick, H. H. et al. (2001), 'MHC class Ia-restricted T cells partially account for beta2-microglobulin-dependent resistance to Mycobacterium tuberculosis', Eur. J. Immunol., Vol. 31, pp. 1944-1949.
62. Sousa, A. O., Mazzaccaro, R. J., Russell, R. G. et al. (2000), 'Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice', Proc. Natl. Acad. Sci. USA, Vol. 97, pp. 4204-4208.
63. Urdahl, K. B., Liggitt, D. and Bevan, M. J. (2003), 'CD8+ T cells accumulate in the lungs of Mycobacterium tuberculosis-infected Kb-/-Db-/- mice, but provide minimal protection', J. Immunol., Vol. 170, pp. 1987-1994.
64. Behar, S. M., Dascher, C. C., Grusby, M. J. et al. (1999), 'Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis', J. Exp. Med., Vol. 189, pp. 1973-1980.
65. Cooper, A. M., D'Souza, C., Frank, A. A. and Orme, I. M. (1997), 'The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin- or granzyme-mediated cytolytic mechanisms', Infect. Immun., Vol. 65, pp. 1317-1320.
66. Laochumroonvrapong, P., Wang, J., Liu, C. C. et al. (1997), 'Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice', Infect. Immun., Vol. 65, pp. 127-132.
67. Cooper, A. M., Dalton, D. K., Stewart, T. A. et al. (1993), 'Disseminated tuberculosis in interferon gamma gene-disrupted mice', J. Exp. Med., Vol. 178, pp. 2243-2247.
68. Flynn, J. L., Chan, J., Triebold, K. J. et al. (1993), 'An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection', J. Exp. Med., Vol. 178, pp. 2249-2254.
69. MacMicking, J. D., North, R. J., LaCourse, R. et al. (1997), 'Identification of nitric oxide synthase as a protective locus against tuberculosis', Proc. Natl. Acad. Sci. USA, Vol. 94, pp. 5243-5248.
70. Scanga, C. A., Mohan, V. P., Tanaka, K. et al. (2001), 'The inducible nitric oxide synthase locus confers protection against aerogenic challenge of both clinical and laboratory strains of Mycobacterium tuberculosis in mice', Infect. Immun., Vol. 69, pp 7711-7717.
71. MacMicking, J. D., Taylor, G. A. and McKinney, J. D. (2003), 'Immune control of tuberculosis by IFN-gamma-inducible LRG-47', Science, Vol. 302, pp. 654-659.
72. Yamada, H., Mizuno, S. and Sugawara, I. (2002), 'Interferon regulatory factor 1 in mycobacterial infection', Microbiol. Immunol., Vol. 46, pp. 751-760.
73. Cooper, A. M., Pearl, J. E., Brooks, J. V. et al. (2000), 'Expression of the nitric oxide synthase 2 gene is not essential for early control of Mycobacterium tuberculosis in the murine lung', Infect. Immun., Vol. 68, pp. 6879-6882.
74. Holscher, C., Atkinson, R. A., Arendse, B. et al. (2001), 'A protective and agonistic function of IL-12p40 in mycobacterial infection', J. Immunol., Vol. 167, pp. 6957-6966.
75. Cooper, A. M., Kipnis, A., Turner, J. et al. (2002), 'Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present', J. Immunol., Vol. 168, pp. 1322-1327.
76. Cooper, A. M., Magram, J., Ferrante, J. and Orme, I. M. (1997), 'Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis', J. Exp. Med., Vol. 186, pp. 39-45.
77. Sugawara, I., Yamada, H. and Mizuno, S. (2003), 'Relative importance of STAT4 in murine tuberculosis', J. Med. Microbiol., Vol. 52, pp. 29-34.
78. Kawakami, K., Kinjo, Y., Uezu, K. et al. (2004), 'Interferon-gamma production and host protective response against Mycobacterium tuberculosis in mice lacking both IL-12p40 and IL-18', Microbes Infect., Vol. 6, pp. 339-349.
79. Kinjo, Y., Kawakami, K., Uezu, K. et al. (2002), 'Contribution of IL-18 to Th1 response and host defense against infection by Mycobacterium tuberculosis: A comparative study with IL-12p40', J. Immunol., Vol. 169, pp. 323-329.
80. Sugawaram, I., Yamada, H., Kaneko, H. et al. (1999), 'Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice', Infect. Immun., Vol. 67, pp. 2585-2589.
81. Saunders, B. M., Frank, A. A., Orme, I. M. and Cooper, A. M. (2000), 'Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection', Infect. Immun., Vol. 68, pp. 3322-3326.
82. Ladel, C. H., Blum, C., Dreher, A. et al. (1997), 'Lethal tuberculosis in interleukin-6-deficient mutant mice', Infect. Immun., Vol. 65, pp. 4843-4849.
83. Yamada, H., Mizumo, S., Horai, R. et al. (2000), 'Protective role of interleukin-1 in mycobacterial infection in IL-1 alpha/beta double-knockout mice', Lab. Invest., Vol. 80, pp. 759-767.
84. Sugawara, I., Yamada, H., Hua, S. and Mizuno, S. (2001), 'Role of interleukin (IL)-1 type 1 receptor in mycobacterial infection', Microbiol. Immunol., Vol. 45, pp. 743-750.
85. Juffermans, N. P., Florquin, S., Camoglio, L. et al. (2000), 'Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis', J. Infect. Dis., Vol. 182, pp. 902-908.
86. Pearl, J. E., Khader, S.A., Solache, A. et al. (2004), 'IL-27 signaling compromises control of bacterial growth in mycobacteria-infected mice', J. Immunol., Vol. 173, pp. 7490-7496.
87. Sugawara, I., Yamada, H., Mizuno, S. and Iwakura, Y. (2000), 'IL-4 is required for defense against mycobacterial infection', Microbiol. Immunol., Vol. 44, pp. 971-979.
88. North, R. J. (1998), 'Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis', Clin. Exp. Immunol., Vol. 113, pp. 55-58.
89. Jung, Y. J., LaCourse, R., Ryan, L. and North, R. J. (2002), 'Evidence inconsistent with a negative influence of T helper 2 cells on protection afforded by a dominant T helper 1 response against Mycobacterium tuberculosis lung infection in mice', Infect. Immun., Vol. 70, pp. 6436-6443.
90. Roach, D. R., Martin, E., Bean, A. G. et al. (2001), 'Endogenous inhibition of antimycobacterial immunity by IL-10 varies between mycobacterial species', Scand. J. Immunol., Vol. 54, pp. 163-170.
91. Jung, Y. J., Ryan, L., LaCourse, R. and North, R. J. (2003), 'Increased interleukin-10 expression is not responsible for failure of T helper 1 immunity to resolve airborne Mycobacterium tuberculosis infection in mice', Immunology, Vol. 109, pp. 295-299.
92. Roach, D. R., Bean, A. G., Demangel, C. (2002), 'TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection', J. Immunol., Vol. 168, pp. 4620-4627.
93. Bean, A. G., Roach, D. R., Briscoe, H. et al. (1999), 'Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin', J. Immunol., Vol. 162, pp. 3504-3511.
94. Flynn, J. L., Goldstein, M. M., Chan, J. et al. (1995), 'Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice', Immunity, Vol. 2, pp. 561-572.
95. Smith, S., Liggitt, D., Jeromsky, E. et al. (2002), 'Local role for tumor necrosis factor alpha in the pulmonary inflammatory response to Mycobacterium tuberculosis infection', Infect. Immun., Vol. 70, pp. 2082-2089.
96. Roach, D. R., Briscoe, H., Saunders, B. et al. (2001), 'Secreted lymphotoxin-alpha is essential for the control of an intracellular bacterial infection', J. Exp. Med., Vol. 193, pp. 239-246.
97. Ehlers, S., Holscher, C., Scheu, S. et al. (2003), 'The lymphotoxin beta receptor is critically involved in controlling infections with the intracellular pathogens Mycobacterium tuberculosis and Listeria monocytogenes', J. Immunol., Vol. 170, pp. 5210-5218.
98. Lu., B., Rutledge, B. J., Gu, L. et al. (1998), 'Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice', J. Exp. Med., Vol. 187, pp. 601-608.
99. Kipnis, A., Basaraba, R. J., Orme, I. M. and Cooper, A. M. (2003), 'Role of chemokine ligand 2 in the protective response to early murine pulmonary tuberculosis', Immunology, Vol. 109, pp. 547-551.
100. Peters, W., Scott, H. M., Chambers, H. F. et al. (2001), 'Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis', Proc. Natl. Acad. Sci. USA, Vol. 98, pp. 7958-7963.
101. Scott, H. M. and Flynn, J. L. (2002), 'Mycobacterium tuberculosis in chemokine receptor 2-deficient mice: Influence of dose on disease progression', Infect. Immun., Vol. 70, pp. 5946-5954.
102. Algood, H. M. and Flynn, J. L. (2004), 'CCR5-deficient mice control Mycobacterium tuberculosis infection despite increased pulmonary lymphocytic infiltration', J. Immunol., Vol. 173, pp. 3287-3296.
103. Seiler, P., Aichele, P., Bandermann, S. et al. (2003), 'Early granuloma formation after aerosol Mycobacterium tuberculosis infection is regulated by neutrophils via CXCR3-signaling chemokines', Eur. J. Immunol., Vol. 33, pp. 2676-2686.
104. Johnson, C. M., Cooper, A. M., Frank, A. A. and Orme, I. M. (1998), 'Adequate expression of protective immunity in the absence of granuloma formation in Mycobacterium tuberculosis-infected mice with a disruption in the intracellular adhesion molecule 1 gene', Infect. Immun., Vol. 66, pp. 1666-1670.
105. Saunders, B. M., Frank, A. A. and Orme, I. M. (1999), 'Granuloma formation is required to contain bacillus growth and delay mortality in mice chronically infected with Mycobacterium tuberculosis', Immunology, Vol. 98, pp. 324-328.
106. Hu, C., Mayadas-Norton, T., Tanaka, K. et al. (2000), 'Mycobacterium tuberculosis infection in complement receptor 3-deficient mice', J. Immunol., Vol. 165, pp. 2596-2602.
107. Leemans, J. C., Florquin, S., Heikens, M. et al. (2003), 'CD44 is a macrophage binding site for Mycobacterium tuberculosis that mediates macrophage recruitment and protective immunity against tuberculosis', J. Clin. Invest., Vol. 111, pp. 681-689.
108. Sebastiani, G., Leveque, G., Lariviere, L. et al. (2000), 'Cloning and characterization of the murine toll-like receptor 5 (Tlr5) gene: sequence and mRNA expression studies in Salmonella-susceptible MOLF/Ei mice', Genomics, Vol. 64, pp. 230-240.
109. Hawn, T. R., Verbon, A., Lettinga, K. D. et al. (2003), 'A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease', J. Exp. Med., Vol. 198, pp. 1563-1572.
110. Muta, T. and Takeshige, K. (2001), 'Essential roles of CD14 and lipopolysaccharide-binding protein for activation of toll-like receptor (TLR)2 as well as TLR4. Reconstitution of TLR2- and TLR4-activation by distinguishable ligands in LPS preparations', Eur. J. Biochem., Vol. 268, pp. 4580-4589.
111. Casanova, J. L. and Abel, L. (2004), 'The human model: A genetic dissection of immunity to infection in natural corditions', Nat. Rev. Immunol., Vol. 4, pp. 55-66.
112. Turner, J., Gonzalez-Juarrero, M., Ellis, D. L. et al. (2002), 'In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice', J. Immunol., Vol. 169, pp. 6343-6351.
113. Zhai, Y., Guo, R., Hsu, T. L. et al. 'LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer', J. Clin. Invest., Vol. 102, pp. 1142-1151.
114. Rutledge, B. J., Rayburn, H., Rosenberg, R. et al. (1995), 'High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens', J. Immunol., Vol. 155, pp. 4838-4843.
115. Brett, S. J. and Ivanyi, J. (1990), 'Genetic influences on the immune repertoire following tuberculous infection in mice', Immunology, Vol. 71, pp. 113-119.
116. Ivanyi, J. and Sharp, K. (1986), 'Control by H-2 genes of murine antibody responses to protein antigens of Mycobacterium tuberculosis', Immunology, Vol. 59, pp. 329-332.
117. Brett, S., Orrell, J. M., Swanson Beck, J. and Ivanyi, J. (1992), 'Influence of H-2 genes on growth of Mycobacterium tuberculosis in the lungs of chronically infected mice', Immunology, Vol. 76, pp. 129-132.
118. Orrell, J. M., Brett, S. J., Ivanyi, J. et al. (1992), 'Morphometric analysis of Mycobacterium tuberculosis infection in mice suggests a genetic influence on the generation of the granulomatous inflammatory response', J. Pathol., Vol. 166, pp. 77-82.
119. Medina, E. and North, R. J. (1998), 'Resistance ranking of some common inbred mouse strains to Mycobacterium tuberculosis and relationship to major histocompatibility complex haplotype and Nramp1 genotype', Immunology, Vol. 93, pp. 270-274.
120. Apt, A. S., Avdienko, V. G., Nikonenko, B. V. et al. (1993), 'Distinct H-2 complex control of mortality, and immune responses to tuberculosis infection in virgin and BCG-vaccinated mice', Clin. Exp. Immunol., Vol. 94, pp. 322-329.
121. Min-Oo, G., Fortin, A., Tam, M. F. et al. (2003), 'Pyruvate kinase deficiency in mice protects against malaria', Nat. Genet., Vol. 35, pp. 357-362.
122. Dormans, J., Burger, M., Aguilar, D. et al. (2004), 'Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB/c mouse model', Clin. Exp. Immunol., Vol. 137, pp. 460-468.
123. Reed, M. B., Domenech, P., Manca, C. et al. (2004), 'A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response', Nature, Vol. 431, pp. 84-87.
124. Hirsh, A. E., Tsolaki, A. G., DeRiemer, K. et al. (2004), 'Stable association between strains of Mycobacterium tuberculosis and their human host populations', Proc. Natl. Acad. Sci. USA, Vol. 101, pp. 4871-4876.